To establish a national center of expertise in regenerative medicine focused on developing and delivering therapies that reestablish tissue and organ function impaired by disease, trauma or congenital abnormalities.
Diabetes Gene Therapy Licensed to Genprex, Inc.
Phase I Clinical Trial Next Step
LEARN MOREMUSCLE REGENERATION
DARPA Awards $22M for ‘Smart’ Device that Regenerates Muscle
LEARN MOREADVANCES IN
Mimicking Cancer to Avoid Transplant Rejection
LEARN MORETECHNOLOGY TRANSFER
Clinical Trials Moving Forward for ALung Technologies, Inc.
Select Your Interest Area
Introduction to The McGowan Institute
To provide a national center of expertise in regenerative medicine. Watch Our Video
McGowan’s Quality Management Specialists Assist Pitt’s Center for Vaccine Research. Read More
Virtual Pitt Health Academy: Research in Orbit. Read More
Dr. Cecelia Yates to Receive the Emerging Innovator Award. Read More